{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:42Z","timestamp":1792788162893,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Foundation Graduate Research Fellowship","award":["DGE-1321846"],"award-info":[{"award-number":["DGE-1321846"]}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG016573"],"award-info":[{"award-number":["AG016573"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG016573"],"award-info":[{"award-number":["AG016573"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["1R21AG056931"],"award-info":[{"award-number":["1R21AG056931"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["1R21AG056931"],"award-info":[{"award-number":["1R21AG056931"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG059407"],"award-info":[{"award-number":["AG059407"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG059407"],"award-info":[{"award-number":["AG059407"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UC Cures Alzheimer\u2019s","award":["BRD-16-501350"],"award-info":[{"award-number":["BRD-16-501350"]}]},{"name":"UC Cures Alzheimer's","award":["BRD-16-501350"],"award-info":[{"award-number":["BRD-16-501350"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UL1 TR000153"],"award-info":[{"award-number":["UL1 TR000153"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) clinical trials require enrollment of a participant and a study partner, whose role includes assessing participant cognitive and functional performance. AD trials now investigate early stages of the disease, when participants are not cognitively impaired. This gives rise to the question of whether study partners or participants provide more information in these trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used data from the AD Cooperative Study Prevention Instrument Project (ADCS-PI) to compare participant and study partner predictions of the participant\u2019s current and future cognitive state. We used the Cognitive Function Instrument (CFI) as a measure of evaluation of the participant\u2019s cognitive status and the modified ADCS Preclinical Alzheimer\u2019s Cognitive Composite (mADCS-PACC) as an objective measure of cognition. Stratifying by cognitive status and study partner type and adjusting for other predictors of the participant\u2019s cognitive state, we used random forests along with estimated mean variable importance (eMVI) to assess how well each member of the dyad can predict cognitive state at current and later visits. We also fit linear regression models at each time point and for each scenario.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants were better at predicting future cognitive status compared to their study partners regardless of study partner type, though the difference between participants and partners was greatest for non-spousal dyads in the lowest-performing quartile. Cross-sectional assessments differed substantially by dyad type. Within the lowest cognitive performance quartile, participants having a non-spousal study partner outperformed their partners in assessing cognition at later times. Spousal partners, in contrast, outperformed participants later in the study in predicting current cognitive performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results indicate that participants tend to be better at predicting future cognition compared to their study partners regardless of the study partner type. When assessing current cognition, however, spousal study partners perform better at later time points and non-spousal study partners do not provide as much information regarding participant cognitive state.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-019-0544-6","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T14:03:37Z","timestamp":1574863417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer\u2019s trials"],"prefix":"10.1186","volume":"11","author":[{"name":"for the Alzheimer\u2019s Disease Cooperative Study","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2031-929X","authenticated-orcid":false,"given":"Michelle M.","family":"Nu\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"issue":"111","key":"544_CR1","doi-asserted-by":"publisher","first-page":"111cm33","DOI":"10.1126\/scitranslmed.3002609","volume":"3","author":"R. A. Sperling","year":"2011","unstructured":"Sperling RA, Jack CR, Aisen PS. Testing the right target and right drug at the right stage. Science Translational Medicine. 2011;3(111):111cm33.","journal-title":"Science Translational Medicine"},{"issue":"4","key":"544_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1377\/hlthaff.2013.1314","volume":"33","author":"JL Watson","year":"2014","unstructured":"Watson JL, Ryan L, Silverberg N, Cahan V, Bernard MA. Obstacles and opportunities in Alzheimer\u2019s clinical trial recruitment. Health Aff. 2014;33(4):574\u20139.","journal-title":"Health Aff"},{"issue":"4","key":"544_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/1471301216648796","volume":"17","author":"BS Black","year":"2018","unstructured":"Black BS, Taylor HA, Rabins PV, Karlawish J. Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role. Dementia. 2018;17(4):494\u2013514.","journal-title":"Dementia."},{"key":"544_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.11.007","volume":"39","author":"JD Grill","year":"2016","unstructured":"Grill JD, Zhou Y, Elashoff D, Karlawish J. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer\u2019s disease clinical trials. Neurobiol Aging. 2016;39:147\u201353.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"544_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00002093-200401000-00003","volume":"18","author":"RE Ready","year":"2004","unstructured":"Ready RE, Ott BR, Grace J. Validity of informant reports about AD and MCI patients\u2019 memory. Alzheimer Dis Assoc Disord. 2004;18(1):11\u20136.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"544_CR6","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1097\/01.wad.0000213870.40300.21","volume":"20","author":"SH Ferris","year":"2006","unstructured":"Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, et al. ADCS prevention instrument project: overview and initial results. Alzheimer Dis Assoc Disord. 2006;20:S109\u2013S23.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"544_CR7","unstructured":"Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1991;41:1588\u20131592."},{"issue":"Supplement 3","key":"544_CR8","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1097\/01.wad.0000213879.55547.57","volume":"20","author":"Sally P. Walsh","year":"2006","unstructured":"Walsh SP, Raman R, Jones KB, Aisen PS, Group AsdCS, others. ADCS prevention instrument project: the Mail-In Cognitive Function Screening Instrument (MCFSI). Alzheimer Disease Associated Disorders. 2006;20:S170-S1S8.","journal-title":"Alzheimer Disease & Associated Disorders"},{"issue":"4","key":"544_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jamaneurol.2014.3375","volume":"72","author":"RE Amariglio","year":"2015","unstructured":"Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, et al. Tracking early decline in cognitive function in older invidividuals at risk for Alzheimer disease dementia: the Alzheimer\u2019s disease Cooperative Study Cognitive Function Instrument. JAMA Neurol. 2015;72(4):446\u201354.","journal-title":"JAMA Neurol"},{"issue":"4","key":"544_CR10","first-page":"668","volume":"3","author":"KV Papp","year":"2017","unstructured":"Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer\u2019s cognitive composite with semantic processing: the PACC5. Alzheimer\u2019s Dementia. 2017;3(4):668\u201377.","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"8","key":"544_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","volume":"71","author":"MC Donohue","year":"2014","unstructured":"Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014;71(8):961\u201370.","journal-title":"JAMA Neurol"},{"issue":"Meeting Abstrac","key":"544_CR12","doi-asserted-by":"publisher","first-page":"P04.205-P04.205","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P04.205","volume":"78","author":"S. Farias","year":"2012","unstructured":"Farias S, Saito N, Harvey D, Aisen P, Petersen R. The validity of self-reported functional decline varies by disease severity. Neurology. 2012;78:P04.205\u2013P04.205.","journal-title":"Neurology"},{"issue":"4","key":"544_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/WAD.0b013e31820d8652","volume":"25","author":"RA Gavett","year":"2011","unstructured":"Gavett RA, Dunn JE, Stoddard A, Harty B, Weintraub S. The Cognitive Change in Women Study (CCW): informant ratings of cognitive change but not self ratings are associated with neuropsychological performance over three years. Alzheimer Dis Assoc Disord. 2011;25(4):305\u201311.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"544_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JAD-161294","volume":"60","author":"C Li","year":"2017","unstructured":"Li C, Neugroschl J, Luo X, Zhu C, Aisen P, Ferris S, et al. The utility of the cognitive function instrument (CFI) to detect cognitive decline in non-demented older adults. J Alzheimers Dis. 2017;60(2):427\u201337.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"544_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1212\/WNL.0b013e31827debfe","volume":"80","author":"JD Grill","year":"2013","unstructured":"Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J. Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 2013;80(3):282\u20138.","journal-title":"Neurology."},{"issue":"1","key":"544_CR16","first-page":"1","volume":"28","author":"JD Grill","year":"2015","unstructured":"Grill JD, Galvin JE. Facilitating Alzheimer\u2019s disease research recruitment. Alzheimer\u2019s Disease Associated Disorders. 2015;28(1):1.","journal-title":"Alzheimer\u2019s Disease Associated Disorders"},{"issue":"1","key":"544_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13195-018-0425-4","volume":"10","author":"EA Largent","year":"2018","unstructured":"Largent EA, Karlawish J, Grill JD. Study partners: essential collaborators in discovering treatments for Alzheimer\u2019s disease. Alzheimers Res Ther. 2018;10(1):101.","journal-title":"Alzheimers Res Ther"},{"key":"544_CR18","first-page":"565","volume":"4","author":"RL Nosheny","year":"2018","unstructured":"Nosheny RL, Camacho MR, Insel PS, Flenniken D, Fockler J, Truran D, et al. Online study partner-reported cognitive decline in the Brain Health Registry. Alzheimer\u2019s Dementia. 2018;4:565\u201374.","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"1","key":"544_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13195-017-0327-x","volume":"9","author":"JD Grill","year":"2017","unstructured":"Grill JD, Karlawish J. Study partners should be required in preclinical Alzheimer\u2019s disease trials. Alzheimers Res Ther. 2017;9(1):93.","journal-title":"Alzheimers Res Ther"},{"issue":"16","key":"544_CR20","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/01.wnl.0000295996.54210.69","volume":"69","author":"JL Cummings","year":"2007","unstructured":"Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology. 2007;69(16):1622\u201334.","journal-title":"Neurology."},{"issue":"6","key":"544_CR21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2014.02.002","volume":"10","author":"JB Langbaum","year":"2014","unstructured":"Langbaum JB, Hendrix SB, Ayutyanont N, Chen K, Fleisher AS, Shah RC, et al. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2014;10(6):666\u201374.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"544_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1037\/0894-4105.22.4.531","volume":"22","author":"ST Farias","year":"2008","unstructured":"Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 2008;22(4):531.","journal-title":"Neuropsychology."},{"key":"544_CR23","doi-asserted-by":"crossref","unstructured":"Ryan MM, Grill JD, Gillen DL. Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer\u2019s disease: study partner vs. participant accuracy. Alzheimer\u2019s Res Ther. 2019;11(1):85.","DOI":"10.1186\/s13195-019-0539-3"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0544-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-019-0544-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0544-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T19:24:50Z","timestamp":1606332290000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-019-0544-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1186\/s13195-019-0544-6","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"30 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Participants signed Institutional Review Board-approved consent forms before enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}